Loestrin 24 Fe Ad Campaign Targets Consumers Not Currently On Birth Control
This article was originally published in The Pink Sheet Daily
Ads for Warner Chilcott’s 24-day oral contraceptive debuted May 15, directing consumers to studies demonstrating a shorter period duration.
You may also be interested in...
A premenstrual dysphoric disorder indication for the low-dose version of Yasmin is still pending.
Warner Chilcott beats out Berlex' Yaz as the first oral contraceptive approved in the U.S. with 24 active hormone days.
The dual GLP-1/GIP agonist outpaced Novo's blockbuster GLP-1 analogue at all three doses, including the important low dose, on A1C reduction and weight reduction in patients with type 2 diabetes.